Medical College of Wisconsin
CTSIResearch InformaticsREDCap

Temporal Dynamics of Oxidative Stress and Inflammation in Bronchopulmonary Dysplasia. Int J Mol Sci 2024 Sep 21;25(18)

Date

09/28/2024

Pubmed ID

39337630

Pubmed Central ID

PMC11431892

DOI

10.3390/ijms251810145

Scopus ID

2-s2.0-85205313212 (requires institutional sign-in at Scopus site)   21 Citations

Abstract

Bronchopulmonary dysplasia (BPD) is the most common lung complication of prematurity. Despite extensive research, our understanding of its pathophysiology remains limited, as reflected by the stable prevalence of BPD. Prematurity is the primary risk factor for BPD, with oxidative stress (OS) and inflammation playing significant roles and being closely linked to premature birth. Understanding the interplay and temporal relationship between OS and inflammation is crucial for developing new treatments for BPD. Animal studies suggest that OS and inflammation can exacerbate each other. Clinical trials focusing solely on antioxidants or anti-inflammatory therapies have been unsuccessful. In contrast, vitamin A and caffeine, with antioxidant and anti-inflammatory properties, have shown some efficacy, reducing BPD by about 10%. However, more than one-third of very preterm infants still suffer from BPD. New therapeutic agents are needed. A novel tripeptide, N-acetyl-lysyltyrosylcysteine amide (KYC), is a reversible myeloperoxidase inhibitor and a systems pharmacology agent. It reduces BPD severity by inhibiting MPO, enhancing antioxidative proteins, and alleviating endoplasmic reticulum stress and cellular senescence in a hyperoxia rat model. KYC represents a promising new approach to BPD treatment.

Author List

Teng M, Wu TJ, Jing X, Day BW, Pritchard KA Jr, Naylor S, Teng RJ

Authors

Kirkwood A. Pritchard PhD Professor in the Surgery department at Medical College of Wisconsin
Ru-Jeng Teng MD Professor in the Pediatrics department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Animals
Anti-Inflammatory Agents
Antioxidants
Bronchopulmonary Dysplasia
Humans
Infant, Newborn
Infant, Premature
Inflammation
Oxidative Stress
Rats